In patients with keratoconus the cornea of the eye begins to bulge. So-called corneal collagen cross-linking aims to halt this process. In this procedure, the cornea is stiffened through locally applied vitamin B2 in combination ...
Nov 30, 2016
0
0
Pembrolizumab (trade name: Keytruda) was initially introduced for the treatment of melanoma. Since July 2016, the monoclonal antibody has also been available for the treatment of locally advanced or metastatic non-small cell ...
Nov 22, 2016
0
0
The fixed combination of trifluridine/tipiracil (trade name: Lonsurf) has been approved since April 2016 for the treatment of metastatic colorectal cancer. The drugs are an option for adult patients with metastatic colorectal ...
Nov 22, 2016
0
0
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy. The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated ...
Oct 25, 2016
0
0
The drug combination sofosbuvir/velpatasvir (trade name: Epclusa) has been approved since July 2016 for the treatment of patients with chronic hepatitis C (CHC). In an early benefit assessment, the German Institute for Quality ...
Oct 17, 2016
0
1
Sitagliptin (trade names: Januvia and Xelevia) is approved for certain adults with type 2 diabetes mellitus whose blood-glucose levels are inadequately controlled by diet and exercise alone. The fixed combination with metformin ...
Oct 13, 2016
0
0
Saxagliptin (trade name: Onglyza) is approved for adults with type 2 diabetes mellitus whose blood-glucose levels are inadequately controlled by diet and exercise alone. The fixed combination with metformin is available under ...
Oct 11, 2016
0
0
Ibrutinib was approved in 2014 for the treatment of certain adults with chronic lymphocytic leukaemia (CLL), particularly as second-line treatment. The therapeutic indication was expanded in 2016. The drug is now also approved ...
Oct 11, 2016
0
0
The drug ticagrelor has been approved since February 2016 for adults who had a myocardial infarction a year or more ago and are at a high risk of a new myocardial infarction or stroke. Ticagrelor is used together with low-dose ...
Oct 7, 2016
0
0
Nivolumab (trade name: Opdivo) in combination with ipilimumab (trade name: Yervoy) has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care (IQWiG) ...
Oct 6, 2016
0
0
